Cost Analysis of Neuromuscular Blockers Purchased by Royal Medical Services during the Years 2014- 2016

: to find out the most cost effective drugs after analyzing the amounts purchased throughout the study period. Methods: studying tenders and/or sub-tenders between “2014-2016” for the daily usage in all Royal Medical Services hospitals. The comparison parameters include: the mean unit price in tender and sub-tender, the total costs, onset and duration of action, side effects profile and the rational for each neuromuscular blocker drug purchased during interval 2014-2016 and set of groups of recommendations and conclusions that insure the cost effectiveness of the items available. Results: Atracurium had the lowest mean cost in one ampoule cost ($1.39), followed by rocuronium ($1.60) and cisatracurium ($2.80). the cost is calculated based on patient assuming to have a weight of 70 kg using one ampoule, further more analyzing sub tenders Atracurium also had the lowest mean cost price in one ampoule ($1.48), followed by rocuronium ($2.22) and cisatracurium ($3.23). The main difference was in rocuronium due to high cost difference between the main tenders and sub tenders. Conclusion: Further investigations are required to determine that the purchases of NMBA's provided the most effective therapy and best cost